Norges Bank Makes New Investment in Balchem Co. (NASDAQ:BCPC)

Norges Bank bought a new position in Balchem Co. (NASDAQ:BCPCFree Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 351,145 shares of the basic materials company’s stock, valued at approximately $52,233,000. Norges Bank owned approximately 1.09% of Balchem as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in BCPC. Comerica Bank purchased a new position in shares of Balchem in the 3rd quarter worth about $11,750,000. William Blair Investment Management LLC grew its position in Balchem by 25.0% during the third quarter. William Blair Investment Management LLC now owns 183,916 shares of the basic materials company’s stock valued at $22,813,000 after acquiring an additional 36,729 shares during the last quarter. Ameriprise Financial Inc. grew its position in Balchem by 9.8% during the third quarter. Ameriprise Financial Inc. now owns 402,621 shares of the basic materials company’s stock valued at $49,941,000 after acquiring an additional 36,011 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new position in shares of Balchem during the third quarter worth approximately $3,783,000. Finally, Grantham Mayo Van Otterloo & Co. LLC lifted its holdings in shares of Balchem by 42.1% in the 3rd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 98,763 shares of the basic materials company’s stock worth $12,251,000 after acquiring an additional 29,265 shares during the last quarter. Institutional investors own 87.91% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. HC Wainwright lifted their target price on shares of Balchem from $167.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, May 6th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Friday, May 10th.

Read Our Latest Stock Report on BCPC

Balchem Stock Performance

NASDAQ:BCPC opened at $152.03 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.72 and a current ratio of 2.61. Balchem Co. has a fifty-two week low of $110.74 and a fifty-two week high of $159.52. The business has a 50 day moving average price of $150.60 and a 200-day moving average price of $144.99. The firm has a market cap of $4.93 billion, a PE ratio of 42.95, a price-to-earnings-growth ratio of 3.61 and a beta of 0.72.

Balchem (NASDAQ:BCPCGet Free Report) last announced its quarterly earnings results on Friday, May 3rd. The basic materials company reported $0.89 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.05). The firm had revenue of $239.66 million during the quarter, compared to the consensus estimate of $234.12 million. Balchem had a return on equity of 11.03% and a net margin of 12.35%. Equities research analysts predict that Balchem Co. will post 3.86 earnings per share for the current year.

Insider Buying and Selling at Balchem

In other news, SVP Michael Robert Sestrick sold 1,929 shares of Balchem stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $154.45, for a total value of $297,934.05. Following the sale, the senior vice president now directly owns 4,878 shares in the company, valued at approximately $753,407.10. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, Director David B. Fischer sold 5,000 shares of the stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $152.98, for a total value of $764,900.00. Following the completion of the transaction, the director now directly owns 9,009 shares of the company’s stock, valued at $1,378,196.82. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Michael Robert Sestrick sold 1,929 shares of Balchem stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $154.45, for a total value of $297,934.05. Following the sale, the senior vice president now directly owns 4,878 shares in the company, valued at $753,407.10. The disclosure for this sale can be found here. 1.25% of the stock is currently owned by corporate insiders.

Balchem Company Profile

(Free Report)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.

Read More

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.